SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-286277
Filing Date
2023-11-30
Accepted
2023-11-30 16:10:02
Documents
12
Period of Report
2023-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d533202d8k.htm   iXBRL 8-K 24850
  Complete submission text file 0001193125-23-286277.txt   146781

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bttx-20231127.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20231127_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20231127_pre.xml EX-101.PRE 11260
6 EXTRACTED XBRL INSTANCE DOCUMENT d533202d8k_htm.xml XML 3378
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 231455911
SIC: 8000 Services-Health Services